"Meanwhile, over 8,000 people are gathering at the JPMorgan healthcare conference in San Franscisco, in another sign of a return to business as usual after the COVID-19 pandemic.
Global pharma companies' efforts to replace revenue from older drugs with promising new ones were largely stymied in 2023, but looming patent expirations and easing financing costs are setting up 2024 well, industry sources say."
8000 attendee's!!
IMU Price at posting:
12.0¢ Sentiment: Hold Disclosure: Held
